Our Mission

The Pershing Square Sohn Prize for Young Investigators in Cancer Research provides young New York-based scientists the freedom to take risks and pursue their boldest research at a stage when traditional funding is lacking.  In the quest for cures, the Prize accelerates the collaboration between academia and industry.  Prize winners each receive $200,000 a year for up to three years.

Our Story

Bill Ackman and Karen Herskovitz established The Pershing Square Foundation in December 2006. Bill is the CEO and Portfolio Manager of Pershing Square Capital Management, L.P. Based in New York, The Pershing Square Foundation has committed $400 million in grants and social investments to support exceptional leaders and innovative organizations that tackle important social issues and deliver scalable and sustainable impact across the globe.

The Foundation’s commitment to be a philanthropic catalyst inspired Bill Ackman to partner with The Sohn Conference Foundation to accelerate cures for cancer. The Sohn Conference Foundation was born from the loss of Ira Sohn, a Wall Street professional who succumbed to cancer at 29. In 1995, his colleagues, friends, and family joined forces to honor his memory. The Sohn Conference Foundation is dedicated to supporting innovative initiatives to cure and treat pediatric cancer. Identifying specific areas of need, the Foundation funds groundbreaking research, state-of-the-art technology, and programs to target cures and improve patient care.

The alliance of these two foundations leverage their respective resources, investigators, and opportunities to exponentially impact the field of cancer research.

The Pershing Square Sohn Cancer Research Alliance is dedicated to pursuing breakthroughs in curing cancer by advancing the most innovative cancer research and by facilitating collaborations between the science and business communities.